{"podcast":{"title":"Biohacking News by Zestology","slug":"biohacking-news-by-zestology-173365","podcast_index_feed_id":173365,"rss_url":"https://zestology.libsyn.com/rss","website_url":"http://sites.libsyn.com/66792/site","image_url":"https://static.libsyn.com/p/assets/3/2/3/2/323215e957904a97d959afa2a1bf1c87/Biohacking_News_by_Zestology_2026_logo.jpg","author":"Tony Wrighton","episode_count":882,"summary":"Biohacking news, reviews, and tech with journalist and author Tony Wrighton. Drawing on years of experience and a bulging contacts book, Tony brings you the biggest stories—and some downright crazy trends—from the world of biohacking. With Dave Asprey, Esther Perel, Paul Saladino, JJ Virgin, Ben Greenfield, Dr. David Sinclair, Joe Wicks, and many more.","last_synced_at":"2026-06-29T08:17:19.525883+00:00","page_url":"https://stenobird.com/podcast/biohacking-news-by-zestology-173365"},"episode":{"title":"Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685","slug":"ozempic-vs-glucose-monitors-feat-sharam-fouladgar-mercer-685","published_at":"2026-03-30T01:00:00+00:00","page_url":"https://stenobird.com/podcast/biohacking-news-by-zestology-173365/ozempic-vs-glucose-monitors-feat-sharam-fouladgar-mercer-685","show_page_url":"https://stenobird.com/podcast/biohacking-news-by-zestology-173365","url":"https://zestology.libsyn.com/ozempic-vs-glucose-monitors-feat-sharam-fouladgar-mercer-685","audio_url":"https://traffic.libsyn.com/secure/zestology/685_BION_Sharam_Fouladgar_Libsyn.mp3?dest-id=270303","summary":"Yet more GLP1 news this week. People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle. So are a tool that biohackers have known about for years - CGMs - the answer? Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management. Follow Sharam Fouladgar-Mercer on LinkedIn.","meta_description":"Yet more GLP1 news this week. People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be dis…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1970,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biohacking-news-by-zestology-173365/episodes/ozempic-vs-glucose-monitors-feat-sharam-fouladgar-mercer-685/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biohacking-news-by-zestology-173365/ozempic-vs-glucose-monitors-feat-sharam-fouladgar-mercer-685.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}